Regions Financial Corp’s PDL BioPharma, Inc. PDLI Stock Holding History

Regions Financial Corp’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-741	Closed	-$3K	–	1972
2019 Q1	$3K	Hold	741	–	–	﹤0.01%	1755
2018 Q4	$2K	Hold	741	–	–	﹤0.01%	1787
2018 Q3	$2K	Buy	741 +316	+74%	+$776	﹤0.01%	1882
2018 Q2	$1K	Hold	425	–	–	﹤0.01%	2064
2018 Q1	$1K	Hold	425	–	–	﹤0.01%	1963
2017 Q4	$1K	Buy	+425	New	+$1.3K	﹤0.01%	2005

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Regions Financial Corp's PDLI Position: Q2 2019 in Review

Regions Financial Corp sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 741 shares — an estimated $3K sold.

Regions Financial Corp first reported a position in PDLI in Q4 2017 and held it in 6 quarters. The position peaked at $3K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

Regions Financial Corp reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 741 PDL BioPharma, Inc. shares in Q2 2019, an estimated $3K.
Regions Financial Corp first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 6 quarters.
Regions Financial Corp's PDL BioPharma, Inc. position peaked at $3K in Q1 2019.
148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.